Cell Reprogramming Takes Center Stage in Biotech's Race to Reverse Aging

Cell reprogramming has emerged as the most hyped anti-aging approach, with Life Biosciences launching its first human trial to regenerate nerve cells in glaucoma patients. However, the field's history—from telomere research to senescent cell therapy—reveals a recurring pattern of initially promising strategies losing momentum after early excitement, raising whether this approach will prove different.